News
Discover our new work around patients’ perce...
The poster "𝘼 𝙉𝙖𝙩𝙪𝙧𝙖𝙡 𝙇𝙖𝙣𝙜𝙪𝙖𝙜𝙚 𝙋𝙧𝙤𝙘𝙚𝙨𝙨𝙞𝙣𝙜 (#𝙉𝙇𝙋) 𝘼𝙥𝙥𝙧𝙤𝙖𝙘𝙝 𝙩𝙤 𝘼𝙪𝙩𝙤𝙢𝙖𝙩𝙚 𝙋𝙖𝙩𝙞𝙚𝙣𝙩𝙨’ 𝙏𝙚𝙨𝙩𝙞𝙢𝙤𝙣𝙞𝙖𝙡𝙨 𝘼𝙣𝙖𝙡𝙮𝙨𝙞𝙨" was written in collaboration with Mélissa...
Our team will present a poster at Journées de Bio...
Quinten Health will be at the Journées de Biostatiques 2022 in Rennes, at the INSA School.Mélissa Rollot (Manager Data Scientist) and Coriande...
We will speak at BiotechX 2022
Quinten Health will be at the Biotech X 22 at Basel Congress Center, Switzerland.Alexandre Templier (President and co-founder) and Frank Ahrens...
Our team will be at ISPOR Europe 2022
Quinten Health will be at ISPOR Europe 2022 in Vienna.Billy Amzal (CEO) will be at ISPOR Europe 2022 from Nov. 6th to Nov. 9th 2022 in Vienna,...
Quinten Health is now OMOP certified by EHDEN (the...
Quinten Health is certified by the European Health Data & Evidence Network (EHDEN) Consortium after their fourth and final call ! This...
Quinten Health, Deeplink Medical, and Institut de ...
Paris, November 15th, 2021 – The partnership will allow INCa (Institut National du Cancer) accredited hospitals of early phase (CLIP) and to...
Aetion and Quinten Health partner to use AI and RW...
Partnership enables global biopharma companies, regulatory agencies, and payers to generate and validate novel insights leveraging real-world...
Key insights from VivaTech 2021 for a pharmaceutic...
We attended Viva Tech 2021 at Sanofi’s booth where we were invited as a preferred partner in artificial intelligence (AI) applied to healthcare....
Quinten Health Partners with Certara to Advance Pr...
Paris, May 27, 2021 – Quinten Health today announced that it is collaborating with Certara, Inc. to offer a unique end-to-end suite of...
Euresis Partners & Quinten Health joined forc...
Paris, April 22, 2021 – Mastering uncertainty has never been so important for healthcare manufacturers. Whether for clinical development, market...
Gustave Roussy and Quinten Health signed a researc...
Paris, March 17, 2021 – After decades of innovation and research in immunotherapy, researchers recently turned to a promising new therapeutic...